PodParley PodParley
GPH 32: Cohort Studies

EPISODE · Mar 19, 2026 · 44 MIN

GPH 32: Cohort Studies

from Clinical Deep Dives · host Dr Manaan Kar Ray

If case–control studies look backward from outcome to exposure, cohort studies begin with exposure and move forward in time to observe outcome.This chapter explores the structure and analytic power of cohort designs.A cohort study identifies groups based on exposure status and follows them prospectively - or retrospectively through existing records - to measure incidence of disease.Cohort studies are particularly valuable for:* Establishing temporal sequence* Calculating incidence directly* Studying multiple outcomes from a single exposure* Investigating rare exposuresKey methodological considerations include:* Selection of exposed and unexposed groups* Minimising loss to follow-up* Controlling confounding* Measuring exposure accurately* Calculating relative risk and attributable riskUnlike case–control studies, cohort designs allow direct estimation of risk and rate.Prospective cohorts offer precision and clarity but can be expensive and time-consuming. Retrospective cohorts leverage existing data but depend on data quality.The chapter also discusses classic long-term cohort studies that reshaped public health understanding of chronic disease risk.Cohort studies provide one of the strongest observational designs for causal inference - short of randomised trials.They allow epidemiology to observe disease emergence in real time.Key Takeaways* Cohort studies begin with exposure classification.* They allow direct calculation of incidence and relative risk.* Establish temporal relationship between exposure and outcome.* Useful for studying multiple outcomes.* Particularly suited for rare exposures.* Loss to follow-up threatens validity.* Prospective and retrospective designs differ in cost and control.* Strong observational evidence for causality. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe

NOW PLAYING

GPH 32: Cohort Studies

0:00 44:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Oncology Today with Dr Neil Love Research To Practice Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice. My Take On It with Your Angelic Karma® Your Angelic Karma Here we take a look at how the United States measures alongside other First World Nations. + taking a deep dive into the science -The Report Metagenics Institute Podcast Metagenics Welcome to the Metagenics Institute Podcast where Healthcare Practitioners can hear innovative, cutting-edge information from leading experts from around the world. Join your host, Nathan Rose, to explore the latest evidence in Natural Health, challenge and debunk industry myths and offer practical, tangible, clinical tools which will transform your practice. The Syndicate Blogcast: Startups | Startup Investing | Tech News | Angel Investors | VC | Venture Capital | Private Equity | Crowdfunding | Fundraising Matt Ward - Serial Entrepreneur | Angel Investor | Startup Advisor | Amazon Ecommerce The Syndicate Blogcast show is an extension of The Syndicate podcast, featuring long form articles on the future technology, ecommerce, business and life. The mini-sodes deconstruct high level startup, business and tech issues to help investors and operators better understand and win the market. Recurring topics include: Facebook, Google, Amazon, Apple, Ecommerce, Blockchains, ICOs, Cryptocurrencies, Marketing, Fundraising, Venture Capital, Startup Challenges, Business Development and more. The Blogcast comes in addition to The Syndicate - the place where investors and startups combine to create crazy businesses and even crazier returns. The Syndicate podcast is a deep dive on the angel investors and VCs behind the big name startups. We interview the best and brightest investors, syndicate leads, GPs, limited partners and startup founders to create an original, off the cuff discussion on startup investing.
URL copied to clipboard!